HR 1169
105th Congress
House
Taxation
Business income tax
Clinical trials
Commerce
Diseases
Drug industry
Health
Income tax
Orphan drugs
Pharmaceutical research
Science, Technology, Communications
Tax credits
To amend the Internal Revenue Code of 1986 to permanently extend the orphan drug credit.
Introduced: March 20, 1997
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 5, 1997
See H.R.2014.
Mar 21, 1997
Sponsor introductory remarks on measure. (CR E550)
Mar 20, 1997
Referred to the House Committee on Ways and Means.
Mar 20, 1997
Introduced in House
Plain-English summary
Amends the Internal Revenue Code to extend permanently the tax credit for expenses of clinical testing of certain drugs for rare diseases or conditions.
What's happening now
See H.R.2014.
Committees of jurisdiction
1